PBEAX
Price
$22.69
Change
-$0.18 (-0.79%)
Updated
Jun 13 closing price
Net Assets
620.81M
VVIAX
Price
$67.63
Change
-$0.55 (-0.81%)
Updated
Jun 13 closing price
Net Assets
188.77B
Interact to see
Advertisement

PBEAX vs VVIAX

Header iconPBEAX vs VVIAX Comparison
Open Charts PBEAX vs VVIAXBanner chart's image
PGIM Jennison Value A
Price$22.69
Change-$0.18 (-0.79%)
VolumeN/A
Net Assets620.81M
Vanguard Value Index Adm
Price$67.63
Change-$0.55 (-0.81%)
VolumeN/A
Net Assets188.77B
PBEAX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PBEAX vs. VVIAX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBEAX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. PBEAX (621M). VVIAX pays higher dividends than PBEAX: VVIAX (2.28) vs PBEAX (1.65). PBEAX was incepted earlier than VVIAX: PBEAX (35 years) vs VVIAX (25 years). PBEAX (0.91) is less costly to investors than VVIAX (0.05). PBEAX is a more actively managed with annual turnover of: 29.00 vs. VVIAX (9.00). PBEAX has a lower initial minimum investment than VVIAX: PBEAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 8.01 vs. PBEAX (4.48). VVIAX return over 5 years is better than : 72.56 vs. PBEAX (47.81).
PBEAXVVIAXPBEAX / VVIAX
Total Expense Ratio0.870.051,740%
Annual Report Gross Expense Ratio0.910.051,820%
Fund Existence35 years25 years-
Gain YTD1.5212.43662%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets621M189B0%
Annual Yield % from dividends1.652.2872%
Returns for 1 year4.488.0156%
Returns for 3 years22.1232.1969%
Returns for 5 years47.8172.5666%
Returns for 10 years14.68103.5414%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XYLO4.96-0.03
-0.60%
Xylo Technologies Ltd
ECX1.58-0.01
-0.63%
ECARX Holdings
MTZ162.10-1.20
-0.73%
MasTec
IBRX3.07-0.12
-3.76%
ImmunityBio
RAPT1.04-0.05
-4.59%
RAPT Therapeutics